LifeVantage announced its preliminary financial results for the second quarter of fiscal 2025. Revenue increased by 31% from the prior year period and 43% sequentially to $67.5 million. Active Accounts in the Americas grew by 22.7% year-over-year and 25.4% sequentially. Globally, Active Accounts grew 12.1% year-over-year and 18.5% sequentially.
The company now expects fiscal 2025 revenue to reside in the range of $235 million to $245 million, up from previous guidance of $200 million to $210 million.
“Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to quickly ramp supply chain and fulfillment capacity to meet the robust demand,” said Steve Fife, LifeVantage President and CEO. “We also saw significant growth in Active Accounts driven by the highest number of enrollments in a quarter since third quarter of fiscal 2019. We look forward to providing more details, including our profitability outlook, when we report our fiscal Q2 results in early February. With business momentum strong, we remain well positioned to deliver significant growth and shareholder value.”
